Deutsche Bank
TSHA icon

Deutsche Bank’s Taysha Gene Therapies TSHA Stock Holding History

Deutsche Bank’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
243,379
+61,610
+34% +$365K ﹤0.01% 2010
2026
Q1 		$813K Buy
181,769
+20,990
+13% +$97.6K ﹤0.01% 2301
2025
Q4 		$884K Buy
160,779
+37,980
+31% +$184K ﹤0.01% 2250
2025
Q3 		$402K Buy
122,799
+15,083
+14% +$42.7K ﹤0.01% 2668
2025
Q2 		$249K Sell
107,716
-26,702
-20% -$58K ﹤0.01% 2845
2025
Q1 		$187K Sell
134,418
-16,665
-11% -$27.9K ﹤0.01% 2980
2024
Q4 		$261K Sell
151,083
-2,409,201
-94% -$5M ﹤0.01% 2979
2024
Q3 		$5.15M Buy
2,560,284
+22,936
+0.9% +$50.3K ﹤0.01% 1272
2024
Q2 		$5.68M Buy
+2,537,348
New +$7.38M ﹤0.01% 1199
2022
Q2 		– Sell
-12,366
Closed -$81K – 4325
2022
Q1 		$81K Sell
12,366
-1,458
-11% -$10.9K ﹤0.01% 3654
2021
Q4 		$161K Buy
13,824
+716
+5% +$10.8K ﹤0.01% 3479
2021
Q3 		$244K Sell
13,108
-414
-3% -$7.87K ﹤0.01% 3464
2021
Q2 		$286K Buy
13,522
+7,670
+131% +$177K ﹤0.01% 3574
2021
Q1 		$119K Sell
5,852
-237
-4% -$6.42K ﹤0.01% 3884
2020
Q4 		$162K Buy
+6,089
New +$131K ﹤0.01% 3585

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank's TSHA Position: Q2 2026 in Review

Deutsche Bank increased its Taysha Gene Therapies (TSHA) stake by 34% in Q2 2026, buying an estimated $365K and bringing the position to 243,379 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2010.

Deutsche Bank first reported a position in TSHA in Q4 2020 and has held it in 15 quarters since. The position peaked at $5.68M in Q2 2024. 208 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Deutsche Bank held 243,379 shares of Taysha Gene Therapies worth $1.66M as of Q2 2026.
  • Deutsche Bank bought 61,610 Taysha Gene Therapies shares in Q2 2026, an estimated $365K.
  • Taysha Gene Therapies made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2010 holding.
  • Deutsche Bank first reported a position in Taysha Gene Therapies in Q4 2020 and has held it in 15 quarters since.
  • Deutsche Bank's Taysha Gene Therapies position peaked at $5.68M in Q2 2024.
  • 208 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.